MYP_042354
Basic Information
Prostate Specific Antigen (Prodrug 2)
Anticancer
Anticancer Prostate cancer targeting
Delivery / Targeting Targeting ligand Prostate cancer targeting
Standard
6 amino acids
C29H50N10O10
Standard
Sequence
HSSKLQ
Physicochemical Analysis
698.77 Da
8.76
0.85
0.59
0.1411
-1.40
0.24
-0.34
80.62
65.00
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
347.07
-4.79
12.0
12.0
24.0
49.0
1.0
6.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0006894 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Mu (Morpholino)
Cyclopamine
Bio-Activity Profile
Anticancer Prostate cancer targeting
Hydrolysis and RP-HPLC
in vitro; 79200 s
RECORD: Rec_0071294 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Succinylation
Amidation
Bio-Activity Profile
Anticancer
0.0093±0.00026 μM
HPLC
Conjuagte 2+PSA(Prostate-specific antigen), in vitro; 43200 s